•
Dec 31, 2024

Corbus Pharmaceuticals Q4 2024 Earnings Report

Expected Revenue:$0
Expected EPS:-$1.22
+48.3% YoY
Total Revenue
$0
Previous year: $1.35M
-100.0%
Gross Profit
-$146K
0
Cash and Equivalents
$149M
Previous year: $13.7M
+988.2%
Free Cash Flow
-$10.9M
Previous year: -$6.01M
+82.1%
Total Assets
$156M
Previous year: $28.3M
+451.3%

Corbus Pharmaceuticals

Corbus Pharmaceuticals